ANATOMY 1 Name of the Department: Department ... - Biomeedikum
ANATOMY 1 Name of the Department: Department ... - Biomeedikum
ANATOMY 1 Name of the Department: Department ... - Biomeedikum
You also want an ePaper? Increase the reach of your titles
YUMPU automatically turns print PDFs into web optimized ePapers that Google loves.
SECTION I: APPENDIXES<br />
17. S. Kõks, A. Soosaar, V. Võikar, V. Volke, M. Ustav, P.T. Männistö, M. Bourin, E. Vasar. Opioid<br />
antagonist naloxone potentiates anxiogenic-like action <strong>of</strong> cholecystokinin agonists in elevated plusmaze.<br />
Neuropeptides, 1998, 32(3); 235-240.<br />
18. J. Kivastik Review: Paediatric reference values for spirometry. Clin Physiology, 1998 (6), 489-497.<br />
19. Volke V, Soosaar A. Kõks S, Vasar E, Männistö PT (1998) L-arginine abolishes <strong>the</strong> anxiolytic-like<br />
effect <strong>of</strong> diazepam in <strong>the</strong> elevated plus-maze test in rats. European Journal <strong>of</strong> Pharmacology 351:<br />
287-290.<br />
20. P.Plakk, P. Liik, P.-H. Kingisepp Hot-wire anemometer for spirography. Med.Biol.Eng.Comput.,<br />
1998, 36, 17-21.<br />
21. R.Raamat, J.Talts, K.Jagomägi, E.Länsimies Ma<strong>the</strong>matical modelling <strong>of</strong> non-invasive oscillometric<br />
finger mean blood pressure measurement by maximum oscillation criterion Med. Biol. Eng. Comp,<br />
1999, 37, 784-788.<br />
22. M. Bourin, M. Malinge, M.C. Colombel, E. Vasar Cholecystokinin receptor agonists block <strong>the</strong><br />
jumping behaviour precipitated in morphine-dependent mice by naloxone. European Neuropsychopharmacology,<br />
1999, 9, 37-43<br />
23. V. Volke, G. Wegener, E. Vasar, R. Rosenberg Methylene blue inhibits hippocampal nitric oxide<br />
synthase activity in vivo. Brain Research, 1999, 826, 303-305.<br />
24. S. Kõks, A. Soosaar, V. Võikar, M. Bourin, E. Vasar BOC-CCK-4, CCKB receptor agonist, antagonizes<br />
anxiolytic-like action <strong>of</strong> morphine in elevated plus-maze. Neuropeptides, 1999, 33, 63-69.<br />
25. S. Kõks, M. Bourin, V. Võikar, A. Soosaar, E. Vasar Role <strong>of</strong> CCK in anti-exploratory action <strong>of</strong> paroxetine,<br />
5-HT reuptake inhibitor. International Journal <strong>of</strong> Neuropsychopharmacology, 1999, 2, 9-16.<br />
26. V. Võikar, A. Sooaar, V. Volke, S. Kõks, M. Bourin, P.T. Männistö, E. Vasar Apomorphine-induced<br />
behavioural sensitization in rats: individual differences, role <strong>of</strong> dopamine and NMDA receptors.<br />
European Neuropsychopharmacology, 1999, 9, 507-514.<br />
27. Soosaar The morph<strong>of</strong>unctional strategies to find neural correlates <strong>of</strong> consciousness. In: Neuronal<br />
Bases and Psychological Aspects <strong>of</strong> Consciousness. London, World Scientific Press, 1999, 541-<br />
545.<br />
28. Wegener G, Volke V, Rosenberg R. (2000) Endogenous nitric oxide decreases hippocampal levels<br />
<strong>of</strong> serotonin and dopamine in vivo. British Journal <strong>of</strong> Pharmacology 130: 575-80.<br />
29. R.Raamat, K.Jagomägi, J.Talts, P.-H.Kingisepp. Effect <strong>of</strong> Peripheral Vasoconstriction on <strong>the</strong> Beatto-Beat<br />
Measurement <strong>of</strong> Finger Blood Pressure. World Congress on Medical Physics and Biomedical<br />
Engineering, Chicago, 22-28. July 2000. 4 pages on CD.<br />
30. R.Raamat, K.Jagomägi, J.Talts. Different Responses <strong>of</strong> Finapres and <strong>the</strong> Oscillometric Finger<br />
Blood Pressure Monitor During Intensive Vasomotion. Journal <strong>of</strong> Medical Engineering & Technology,<br />
2000, 24, 3, 95-101.<br />
31. A.Nurmekivi, P.-H.Kingisepp. Capacity <strong>of</strong> <strong>the</strong> respiratory system and <strong>the</strong> potential to influence it.<br />
Modern athlete and coach, 2000, 38, 8-12.<br />
32. S. Kõks, P.T. Männistö, M. Bourin, J. Shlik, V. Vasar, E. Vasar Cholecystokinin (CCK) in <strong>the</strong> rat<br />
plus-maze model <strong>of</strong> anxiety B a possible relation to human disorders. Journal <strong>of</strong> Psychiatry & Neuroscience,<br />
2000, 25, 33-42.<br />
33. A. Veraksits, I. Bileviciute-Ljungar, J. Maaroos, E. Vasar, T. Lundeberg Neuronal mechanisms<br />
contribute to corticotropin-releasing factor-induced anti-oedema effect in <strong>the</strong> rat hind paw. Neuropeptides,<br />
2000, 34, 129-134.<br />
34. Wegener G, Volke V, Bandpey Z, Rosenberg R. (2001) Nitric oxide modulates lithium-induced conditioned<br />
taste aversion. Behavioral Brain Research 118: 195-200.<br />
PAPERS IN ESTONIAN JOURNALS<br />
1. Jagomägi K., Viigimaa M., Hendrikson E., Talts J., Raamat R., Teesalu R. Arteriaalse vererõhu ja<br />
südame löögisageduse variaabelsuse määramine funktsionaalsete testide ajal. südamelihase infarkti<br />
ägedas faasis. Eesti Arst, 1996, 2, 105-108<br />
62. J. Kivastik, P.-H. Kingisepp Voolu-mahu lingu näitajate hajuvus laste kordusuuringutel. Eesti Arst,<br />
1996, 5, 410-412.<br />
63. P.-H. Kingisepp, J. Kivastik Lämmastiku üksihingamistesti rakendamisest kopsude funktsionaalse<br />
seisundi hindamisel. Eesti Arst, 1997, 5, 396-400.<br />
64. P.-H.Kingisepp, V.Pert Kopsude difusioonivõime määramine CO üksikhingamispeetuse meetodil<br />
Eesti Arst 1998, 6, 499-501.<br />
65. R.Raamat, J.Talts, K.Jagomägi. Theoretical study <strong>of</strong> discrepancies in estimation <strong>of</strong> mean blood<br />
pressure by Marey’s criterion. Proc. Estonian Acad. Sci. Eng., 1999, 5, 4, 281-292.<br />
66. P.-H.Kingisepp Georg Kingisepa meditsiiniõpingutest Heidelbergis. Eesti Arst, 1999, 2, 166-171.<br />
82